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Seasonal malaria chemoprevention (SMC) has been shown to be highly efficacious against
clinical malaria in areas where transmission is acutely seasonal. SMC targeting depends on
a complex interplay of climate, malaria transmission and population distribution. In this
study a spatial decision support framework was developed to identify health districts suit-
able for the targeting of SMC across seven Sahelian countries and northern states of Nige-
ria that are members of the Nouakchott Initiative.
Methods
A spatially explicit decision support framework that links information on seasonality, age-
structured population, urbanization, malaria endemicity and the length of transmission sea-
son was developed to inform SMC targeting in health districts. Thresholds of seasonality,
population and receptive risks were defined to delineate SMC suitable health districts and
define the age range of children for targeting. Numbers of children were then computed for
the period 2015–2020 in SMC districts. For 2015, this was combined with maps of length of
malaria transmission seasons and WHO recommended treatment regimen to quantify the
number of tablets required across the SMC health districts.
Results
A total of 597 Sahelian health districts were mapped, out of which 478 (80.1%) were consid-
ered suitable for SMC based on seasonality and endemicity thresholds. These districts had
an estimated 119.8 million (85%) of the total population in 2015. In the six years from 2015–
2020, it is estimated that a total of 158 million children 3m to <5 years, 121 million of whom
were in rural areas, will need SMC to achieve universal coverage in the Sahel. If the upper
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age limit of SMC targeted children was increased to <10 years in low transmission districts,
a total 177 million overall, of whom 135 million were rural children, will require chemopre-
vention in 2015–2020. In 2015 alone, an estimated 49–72 million SP tablets and 148–217
million AQ tablets will be needed to cover all or rural children respectively under the different
scenarios of upper age limits.
Conclusions
Our proposed framework provides a standardised approach to support targeting and scale
up of SMC by the countries of the Nouakchott Initiative. Our analysis suggests that the vast
majority of the population in this region are likely to benefit from SMC and substantial
resources will be required to reach universal coverage each year.
Introduction
Seasonally targeted intermittent preventive treatment of malaria in children, also known as sea-
sonal malaria chemoprevention (SMC), has been shown, under trial conditions, to prevent
approximately 75% of clinical malaria episodes, including severe malaria, in areas where trans-
mission is concentrated within a few months of the year [1,2]. In February 2012, the World
Health Organization (WHO) approved a recommendation for the use of sulphadoxine-pyri-
methamine plus amodiaquine (SP+AQ) for SMC in children aged 3 months to below 5 years
administered at monthly intervals during the transmission season, principally in the Sahelian
region of Africa [3]. In May 2013, the Nouakchott Initiative was signed by the governments of
The Gambia, Chad, Mali, Mauritania, Niger and Senegal to accelerate and coordinate the fight
against malaria in these six countries [4]. This was later expanded to include Burkina Faso and
Nigeria, with the SMC focus in the latter on the nine northern States.
SMC targeting depends on a complex interplay of seasonality, the length of the transmission
seasons, endemicity, population distribution and urbanisation. Where routine health systems
remain weak, the most reliable sources of malaria risk are those that predict the intensity of P.
falciparum transmission [5]. However, their use for defining endemicity thresholds for SMC is
not straightforward. Previous analysis on defining SMC target population relied on recent pre-
dictions of malaria transmission intensity to define endemicity thresholds for SMC suitable
areas and produced national estimates of target populations [6]. The use of the most recent
malaria risk maps to define endemicity thresholds for SMC suitability, however, may exclude
areas that have acute malaria seasonality but have transitioned to low levels of transmission.
Where transmission potential in such areas is high due to the continued presence of efficient
vectors and large numbers of asymptomatic human hosts, SMC is critical to sustain low disease
incidence and maps of receptive risks are better suited to defining endemicity thresholds for
SMC. Conversely, as transmission declines to very low levels, the age pattern and the clinical
burden posed by P. falciparum infection changes, with older children at greater risk [7,8].
Increasing the potential maximal benefit may require expanding SMC to cover older children
and recent malaria risk maps should be used for such a decision. To support quantification of
resources for sub-national scale up of SMC, suitability must also be resolved to health decision-
making units, and within these units, information on population by residence (urban vs rural)
and the number of months of malaria transmission are required.
In this study, we develop a spatial decision support framework that captures the interplay of
seasonality, age-structured population, urbanization, endemicity and the length of transmission
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season to inform SMC targeting in Burkina Faso, Chad, Gambia, Mali, Mauritania, Niger, Sene-
gal and nine northern states of Nigeria (Bauchi, Borno, Jigawa, Kano, Katsina, Kebi, Sokoto,
Yobe and Zamfara). Layers of information are assembled and analysed to empirically quantify
each element of the SMC spatial decision support framework. SMC health districts are defined
and the numbers of target children by age range are estimated for the period 2015–2020, coin-
ciding with the baseline and the first milestone years of the newWHOGlobal Technical Strat-
egy for malaria [9]. For illustration, this information is then used to quantify the amount of
tablets required for 2015 across the SMC health districts.
Materials and Methods
A spatial decision support framework for SMC targeting
The spatial decision support framework for SMC targeting that we propose in this study (Fig 1)
is different to previous work [6] in several important aspects. A 2000 P. falciparummalaria risk
map [5], an approximate measure of receptive risks prior to the large scale up of malaria inter-
ventions, is used to define endemicity thresholds for SMC suitability. A 2010 P. falciparum
malaria risk map [5] is used to identify areas where the option of increasing the age class of tar-
get children from 3 months to below 5 years to up to below 10 years may confer greater benefit
from SMC. We resolve Information to current health decision-making units, known as health
districts, and age-structured populations within their boundaries are classified into urban and
rural. The numbers of children that require SMC are estimated for the period 2015–2020 using
population projections. Finally, median number of malaria transmission months is computed
per health district to allow for the quantification of the amount of SP and AQ tablets required
to achieve universal coverage in SMC districts in 2015.
Assembly of input spatial data and layers
Detailed descriptions of the assembly of spatial layers of information are provided in the foot-
notes for Fig 1 and the accompanying S1 File. In brief, information from UN approved second-
level administrative boundary demarcations [10,11], the most recent national health strategic
plans, national malaria control plans, health financing plans, Ministry of Health websites and
correspondence with WHO offices and National Malaria Control Programme managers were
used to define the boundaries of health districts in the 7 Sahelian countries and the nine states
of northern Nigeria (Section A and B in S1 File).
Population density mapping techniques [12,13] were used to allocate population counts at 1
x 1 km resolutions across the study countries based on the most recent, highest resolution pop-
ulation census data and remotely sensed land-cover classification systems. This approach was
extended to further classify populations into urban and rural based on population density,
night time lights and other land cover classifications. The modelled population estimates were
projected to 2015–2020 using national rural and urban growth rates estimated by the UN Pop-
ulation Division [14]. Data on sub-national population age structures was obtained from a
variety of sources and used to derive adjustments of the population density by the age catego-
ries of 3 months to below 5 years; 5 years to below 10 years and 10 years (Section C in S1
File).
An approach developed by Cairns and colleagues [6] was adopted to define areas of acute
seasonal transmission as those where 60% or more of the annual total rainfall occurred in three
consecutive months. To replicate this approach, daily rainfall estimates from the Africa Rainfall
Estimates version 2 (RFE 2.0) data from 2002–2009 [15] were resampled to 1 x 1 km spatial
resolution and used to identify seasonal areas (Section D in S1 File). For each health district the
proportion of the population that was located in areas where60% of rainfall occurred within
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any 3 consecutive months was computed. Health districts were identified as seasonal if 80% of
population lived in areas where> = 60% of rainfall occurred in 3 consecutive months.
Within health districts that were identified as seasonal, the median number of transmission
months was extracted from a map obtained from the International Research Institute for Cli-
mate and Society website [16,17]. This map was developed from long-term rainfall and temper-
ature data and their theoretical relationships with P. falciparummalaria transmission [17]. The
map of number of transmission months was defined at spatial resolution of approximately 50 x
50 km and was resampled to 1 x 1 km to match the seasonality maps.
Recently published continuous maps predicted from community Plasmodium falciparum
parasite rate (PfPR) data standardised to the age range 2 to just below 10 years (PfPR2-10) at
1 × 1 km spatial resolution for the year 2000 and 2010 was used to define receptive and current
risks respectively [5]. The continuous PfPR2-10 surfaces were used together with the population
distribution surfaces for the same year at matching 1 × 1 km spatial resolutions to compute
population adjusted PfPR2-10 (PAPfPR2-10) by health district for both 2000 and 2010. To com-
pute PAPfPR2-10, the mean proportion of the posterior PfPR2-10 for a given year was multiplied
with the pixel level population surface to estimate the numbers of people who were likely to be
infected per pixel for that year, which was then summed for each health district. The estimated
population that was infected was divided by the total population of the health districts for that
year to generate the mean PAPfPR2-10, (Section F in S1 File).
Fig 1. A spatial decision support framework for identifying areas suitable for seasonal chemoprevention and quantifying the size of the population
of target children and the amount of the required antimalarial tablets. For additional details of the definition of inputs, processes and outputs see the S1
File.
doi:10.1371/journal.pone.0136919.g001
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SMC target health districts, population of children and antimalarial
tablets
Health districts were identified as suitable for SMC if they were seasonal (>80% of population
lived in areas where> = 60% of rainfall occurred in 3 consecutive months) and had 2000
PAPfPR2-10 (receptive risk) of5%. Within these SMC health districts, children 3 months to
below 10 years were targeted in those where transmission was 5% to 10% PAPfPR2-10 in 2010.
In districts where transmission PAPfPR2-10 in 2010 as>10%, SMC was targeted at children 3
months to below 5 years. Projected population of SMC targeted children by age class were
extracted for each year from 2015 to 2020 for each health district. Using the year 2015 for illus-
tration, the estimated number of SMC targeted children was multiplied by the median number
of malaria transmission months per health district and the SP and AQ tablets required per
child per month (Section G in S1 File).
Results
Fig 2A shows population distribution map at 1 × 1 km spatial resolution, on which the bound-
aries of the updated health districts overlay, demonstrating an increasing density of population
north to south at increasing distance from the Sahara Desert. Areas that have acute malaria sea-
sonality, however, were concentrated in the middle Sahelian belt and excluded several of the
extremely arid northern districts and the humid districts in the Equatorial south (Fig 2B).
Within the seasonal areas the number of months of transmission increased southwards with
most districts having a median 3 of months (Fig 2C). Estimated receptive P. falciparum trans-
mission intensity, as measured by PAPfPR2-10 in 2000 (Fig 2D), showed increasing rates north
to south with almost all the districts in northern arid areas having infection rates of<5%.
Out of the 597 Sahelian health districts in the eight countries, 543 (90.1%) had the defined
receptive risk threshold suitable for SMC of5% PAPfPR2-10 in 2000 (Fig 2C and Table 1). A
total of 514 health districts also met the seasonality criterion of 80% of the 2000 population liv-
ing in areas where60% of rainfall occurring in three consecutive months (Table 1). 478
(80.1%) health districts met both criteria of a 2000 endemicity of>5% PAPfPR2-10 and 80% of
the population lived in areas where60% of rainfall occurring in three consecutive months
and were therefore considered suitable for SMC (Table 1 and Fig 3). The health districts in the
nine northern states of Nigeria (Bauchi, Borno, Jigawa, Kano, Katsina, Kebi, Sokoto, Yobe and
Zamfara) accounted for about 38% of all SMC suitable districts (Table 1). In The Gambia and
Senegal all the health districts were identified as suitable for SMC. An estimated 85% of the
population in the Sahel or 119.8 million in 2015, increasing to 139.1 million by 2020, were in
the SMC suitable health districts (Table 1).
If the WHO recommendation of targeting only children 3 months to below five years was
applied, a total of 158 million children, including 121.5 million in rural areas, will need SMC to
achieve universal coverage in all targeted health districts in the six years from 2015–2020
(Table 2). Approximately 40% of these children were from Nigeria regardless of whether all or
only rural districts were targeted. Burkina Faso, Mali, Niger and Senegal were the other coun-
tries that contributed the largest target population and together with Nigeria accounted for
over 90% of all targeted children in the SMC districts. The countries where the exclusion of the
urban areas resulted in the largest absolute reductions in population were Nigeria (13.5 mil-
lion), Senegal (5.7 million), Mali (5.4 million) and Burkina Faso (5.3 million).
If the age of children to be targeted with SMC was expanded to children 3 months to below
10 years in 123 health districts where PAPfPR2-10 was 5% to10% in 2010 a total of 177.1 chil-
dren, including 134.7 million in rural areas, would require SMC between 2015–2020 (Table 2).
The countries most affected by the expansion of the age of children were Senegal and Niger
Sub-National Targeting of Seasonal Malaria Chemoprevention
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Fig 2. Map of Sahelian health districts (n = 597) showing A) the distribution of population in 2015 at 1 x
1 km spatial resolution [source: www.worldpop.org]; B) areas (orange) where 60% or more of the
annual total rainfall occurs in any three consecutive months; C) the median number of malaria
transmission months in an average year in seasonal health districts [source: Grover-Kopec et al
2006; D) population adjusted estimates of P. falciparum parasite rate standardized to the ages 2 to 10
years (PAPfPR2-10) for the year 2000 [source: Noor et al 2014]. In Nigeria, health districts from the states
of Bauchi, Borno, Jigawa, Kano, Katsina, Kebi, Sokoto, Yobe and Zamfara were included in the analysis.
doi:10.1371/journal.pone.0136919.g002
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where additional 9.8 million and 3.7 million children required SMC. There were no health dis-
tricts in Burkina Faso that met the criterion for including older children.
The amount of tablets required for 2015 was computed from the population size of targeted
children (Table 2), the number of SP and AQ tablets per transmission month based on WHO
recommendations and the median number of malaria transmission months per year (Fig 1C).
It is estimated that if children 3 months to below 5 years of age across all SMC districts were
targeted, 64 million SP and 192 million AQ tablets would be required in 2015 (Table 3). If,
however, children 3m to<10 years were additionally covered in health districts where
PAPfPR2-10 was 5% to10% in 2010, 72 million SP and 217 million AQ tablets will be
required. Focusing on rural children only reduced the amount of tablets required from 49 mil-
lion and 55 million SP tablets and 148 and 164 million AQ tablets depending on the ages of
children included.
Discussion
National Malaria Control Programmes in the Sahel, that form part of the Nouakchott Initia-
tive, have previously used a wide range of risk maps to coordinate their activities (S1 File).
These maps, which are expert-opinion, based on climate suitability or aggregated representa-
tions of parasite prevalence from recent household surveys, do not provide a single standard
metric across countries for sub-national SMC planning. They are also not presented in ways
that are helpful to allocate resources within health decision-making units. The sub-national
SMC targeting approach we have developed in this study not only recognizes the need to sup-
port decentralized health decision-making but provides a common decision making platform
across the countries of the Nouakchott Initiative. It also potentially provides a complementary
frontend for the SMC implementation toolkit developed by the WHO Global Malaria Pro-
gramme, in collaboration with the Medicines for Malaria Venture (MMV) [18] that focuses on
planning, training and communication to guide the process of actual delivery of the interven-
tion to communities and subsequent monitoring and evaluation.
Table 1. A summary of the health districts and population in the countries of the Nouakchott Initiative for targeting of seasonal malaria chemopre-
vention (SMC) in the Sahel from 2015–2020.
Burkina
Faso
Chad Gambia Mali Mauritania Niger Nigeria Senegal Total
Total number of districts 70 62 7 60 53 42 227 76 597
Number of districts where PAPfPR2-10 was greater 5% 70 44 7 56 26 38 227 75 543
Number of districts where >80% of population lived in
seasonal areas
57 39 7 53 43 41 198 76 514
Number of districts suitable for SMC 57 25 7 52 26 38 198 75 478
Number of SMC districts children 3 months to 10 years
should be targeted (5% to 10% PAPfPR2-10 in 2010)
0 11 7 5 26 12 0 62 123
Total population (millions) by year in SMC targeted
districts
2015 15.7 6.3 2.0 14.8 2.4 18.6 45.3 14.7 119.8
2016 16.2 6.5 2.0 15.3 2.4 19.4 46.5 15.1 123.4
2017 16.7 6.7 2.1 15.8 2.5 20.1 47.7 15.5 127.1
2018 17.2 6.9 2.2 16.3 2.5 20.9 49.0 16.0 131.0
2019 17.7 7.1 2.2 16.8 2.6 21.8 50.4 16.5 135.1
2020 18.2 7.3 2.3 17.3 2.6 22.6 51.8 16.9 139.0
Total 101.7 40.8 12.8 96.4 14.9 123.4 290.6 94.7 775.3
doi:10.1371/journal.pone.0136919.t001
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Our analysis shows that over 85% of all the population of the Nouakchott Initiative region
live in areas that are suitable for SMC, and the nine states of Nigeria alone contribute 40% of
this population. The WHO currently recommends that only children 3 months and below 5
years of age are targeted with SMC in the Sahel and sub-Sahel [3] resulting in 158 million chil-
dren that need to be reached with the intervention over the period 2015–2020. Approximately
34 million of these children are from urban areas. However, there are no clear guidelines on
whether urban populations in SMC suitable areas should be targeted for malaria chemopreven-
tion. Overall malaria infection rates are lower in urban compared to neighbouring rural areas
Fig 3. Map of the Sahel showing the health districts that are not suitable for SMC targeting (grey n = 119) and SMC suitable health districts (light to
dark brown, n = 478) classified by age class of target children. The SMC suitable districts were those where PAPfPR2-10 in 2000 was5% and 80% of
the population lived in areas where60% or more of the annual total rainfall occurs in any three consecutive months. In SMC health districts where PAPfPR2-
10 in 2010 was5% to 10% (n = 123) children 3 months to <10 years of age were targeted for SMCwhile those where it was >10% (n = 355) children 3
months to <5 years of age were targeted. *All inputs are either generated at or resampled to surfaces of 1 x 1 km spatial resolutions. A) Monthly Africa
Rainfall Estimates version 2 (RFE 2.0) data from 2002–2009 at 10 × 10 km spatial resolution [NOAA 2013] were used to generate average long term monthly
rainfall which are then used to define average seasonality (Section D in S1 File); B) Maps of total population are disaggregated by age structure (3 months to
below 5 years; 5 years to below 10 years) using data from census and household surveys and by urban and rural using population density, night time lights
and other land cover classifications (Section C in S1 File). Countries should use most recent census and survey data for population projections and age
categorisations; C) For all countries except Niger and Mauritania PfPR2-10 data from the period 1980–2012 were used to estimate endemicity from 2000 and
2010 (Section F in S1 File). D) A map based on the presumed relationship between P. falciparum transmission, temperature and rainfall to define the length
of transmission seasons was downloaded as a grid surface from International Research Institute for Climate and Society website [IRI URL]. The map was at
spatial resolution of approximately 50 x 50 km and was resampled to 1 x 1 km (Section E in S1 File); E) The approach by Cairns et al (2012) that identified
acute malaria seasonality as areas where 60% or more of the annual total rainfall occurred in three consecutive months was used. This approach had a high
sensitivity (95%) of areas where over 60% of malaria cases occurred in 4 consecutive months (Section D in S1 File,); F) Data from a variety of international
and national sources were used to develop the most recent boundaries of health districts (Section B in S1 File). Due to population growth and changes in
governance health districts change frequently and countries should continuously update these boundary changes.G-J) Health districts where80% of
population lived in areas of acute malaria seasonality and had 2000 PAPfPR2-10 5%were considered suitable for SMC (Section F in S1 File). This
endemicity threshold allowed for the inclusion of areas where current risk is low but where receptive risk is still high. Population estimates by age class, urban
and rural were extracted to each health district (S1 File); K) In districts where 2010 PfPR2-10 was 5% to10%, children aged 3 months to <10 years were
targeted for SMC and 3 to months to <5 years in higher transmission districts (Section F in S1 File). Countries can update the contemporary description of risk
using most recent survey data. A decision also needs to be made on whether or not to include urban areas. L) The median number of transmission months
was extracted for each health district from the climate based map of length of transmission (Section E in S1 File) and was multiplied by the estimated number
of SMC targeted children and the 1 SP and 3 AQ tablets per child per month (Section F in S1 File).
doi:10.1371/journal.pone.0136919.g003
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of Africa [19, 20] but may have areas of high receptivity that are at risk of upsurge in transmis-
sion due seasonal human population movements [21] suggesting a potential benefit from
SMC. There are also many other features of urban life not captured by exposure risk alone,
including accessibility to curative services and household economies but the evidence on the
efficacy of SMC in urban areas remains limited.
In addition to seasonality, an accurate understanding of malaria endemicity is key to identi-
fying areas suitable for SMC. In this study we argue that the use of contemporary measures of
malaria risk to identify SMC suitable areas [6] would exclude districts where malaria incidence
has reduced to low levels [5] but still have substantial transmission potential. For example, the
map for Senegal that is currently used for planning [Fig A in S1 File] is one of regional
Table 2. Estimated target population (millions) of children in SMC health districts in in the countries of the Nouakchott Initiative from 2015–2020
by age range and residence.
Target
population
Age class of target children Year Burkina
Faso
Chad Gambia Mali Mauritania Niger Nigeria Senegal Total
3 months to below 5 years in all
districts
2015 2.6 1.1 0.3 2.7 0.4 3.6 9.2 2.3 22.2
2016 2.8 1.2 0.4 2.9 0.4 4.1 10 2.5 24.2
2017 2.9 1.3 0.4 3.1 0.4 4.4 10.5 2.6 25.6
2018 3 1.3 0.4 3.3 0.4 4.7 11.1 2.8 27.1
2019 3.2 1.4 0.4 3.5 0.4 5.1 11.7 2.9 28.7
2020 3.3 1.5 0.5 3.7 0.4 5.5 12.3 3.1 30.4
All Total 17.7 7.7 2.4 19.2 2.4 27.4 64.8 16.3 158
3 months to below 10 years in SMC
districts with PAPfPR2-10 5% to 10%
and 3 months to below 5 years in
districts >10% PAPfPR2-10
2015 2.6 1.4 0.6 2.8 0.7 4.4 9.2 4.1 25.7
2016 2.8 1.5 0.6 3 0.7 4.8 10 4.2 27.5
2017 2.9 1.5 0.6 3.2 0.7 5 10.5 4.3 28.8
2018 3 1.6 0.6 3.4 0.7 5.3 11.1 4.3 30.1
2019 3.2 1.6 0.7 3.6 0.7 5.6 11.7 4.5 31.6
2020 3.3 1.7 0.7 3.8 0.8 6.1 12.3 4.7 33.5
Total 17.7 9.4 3.8 19.9 4.3 31.2 64.8 26.1 177.1
3 months to below 5 years in all
districts
2015 1.9 0.8 0.2 2 0.4 3.2 7.5 1.5 17.4
2016 2 0.9 0.2 2.1 0.4 3.5 8 1.7 18.8
2017 2 1 0.2 2.3 0.4 3.8 8.4 1.7 19.7
2018 2.1 1 0.2 2.4 0.4 4.1 8.8 1.8 20.8
2019 2.2 1.1 0.3 2.5 0.4 4.4 9.2 1.9 21.8
2020 2.2 1.1 0.3 2.6 0.4 4.7 9.6 2 23
Rural Total 12.4 5.9 1.4 13.9 2.4 23.7 51.3 10.6 121.5
3 months to below 10 years in SMC
districts with PAPfPR2-10 5% to 10%
and 3 months to below 5 years in
districts >10% PAPfPR2-10
2015 1.9 1 0.3 2.1 0.7 3.8 7.5 2.7 19.8
2016 2 1 0.3 2.2 0.7 4.1 8 2.7 21.1
2017 2 1.1 0.4 2.3 0.7 4.3 8.4 2.8 22
2018 2.1 1.1 0.4 2.5 0.7 4.6 8.8 2.8 22.9
2019 2.2 1.2 0.4 2.6 0.7 4.8 9.2 2.9 23.9
2020 2.2 1.2 0.4 2.7 0.8 5.2 9.6 3 25.1
Total 12.4 6.6 2.2 14.3 4.3 26.8 51.3 16.9 134.7
doi:10.1371/journal.pone.0136919.t002
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summary of parasite prevalence from the 2011 malaria indicator survey highlighting the cur-
rent low prevalence and suggests that large parts of Senegal, on the basis of transmission inten-
sity and corresponding disease incidence, are not suited to SMC. The use of contemporary
malaria endemicity maps also assumes that ITN coverage [22] or resistance to pyrethroids in
the Sahel [23,24] will remain at current levels. These are both high-risk scenarios given the cur-
rent financial constraints to overseas development assistance and domestic health funding [22]
and the presence of pyrethroid resistance in the sub-region. Instead, we have used estimates of
P. falciparum transmission in 2000, prior to the large scale up of malaria control in Africa and
a reasoned estimate of receptive risks, to define endemicity thresholds for SMC suitability.
We propose an alternative role for contemporary maps of malaria endemicity where,
instead of using them to define endemicity thresholds for SMC suitability, we apply them to
determine where to expand the upper age limit of children to be targeted. In areas where
Table 3. Estimated numbers of SP and AQ tablets required in SMC health districts in in the countries of the Nouakchott Initiative in 2015. To com-
pute the total tablets, the estimated population of targeted children was multiplied by the number of tablets per child for SP and AQ separately and the number
of months of transmission in a health district. TheWHO guidelines [WHO 2013] recommend that a child is given one tablet of SP and 3 tablets of AQ during
each transmission month. In 24 health districts where the estimated median months of transmission was >4, we have assumed a 4-month transmission sea-
son to adhere to the WHO recommendation that SMC should last no more than 4 months.
Target
population
Age class of target children Drug Burkina
Faso
Chad Gambia Mali Mauritania Niger Nigeria Senegal Total
All 3 months to below 5 years in all
districts
SP 7.8 3.5 1.2 8.4 0.7 7.5 27.9 7 64
AQ 23.5 10.5 3.6 25.1 2.2 22.4 83.8 20.9 192.1
3 months to below 10 years in SMC
districts with PAPfPR2-10 5% to
10% and 3 months to below 5 years
in districts >10% PAPfPR2-10
SP 7.8 4.4 2.1 8.5 1.5 8.9 27.9 11.4 72.4
AQ 23.5 13.1 6.4 25.5 4.4 26.6 83.8 34.1 217.3
Rural 3 months to below 5 years in all
districts
SP 5.7 2.7 0.7 6 0.7 6.3 22.7 4.6 49.4
AQ 17 8 2 17.9 2.2 19 68 13.9 148.2
3 months to below 10 years in SMC
districts with PAPfPR2-10 5% to
10% and 3 months to below 5 years
in districts >10% PAPfPR2-10
SP 5.7 3.1 1.1 6.1 1.5 7.5 22.7 7.3 54.8
AQ 17 9.2 3.4 18.2 4.4 22.4 68 21.8 164.4
Target
population
Age class of target children Drug Burkina
Faso
Chad Gambia Mali Mauritania Niger Nigeria Senegal Total
All 3 months to below 5 years in all
districts
SP 7.8 3.5 1.2 8.4 0.7 7.5 27.9 7 64
AQ 23.5 10.5 3.6 25.1 2.2 22.4 83.8 20.9 192.1
3 months to below 10 years in SMC
districts with PAPfPR2-10 5% to 10%
and 3 months to below 5 years in
districts >10% PAPfPR2-10
SP 7.8 4.4 2.1 8.5 1.5 8.9 27.9 11.4 72.4
AQ 23.5 13.1 6.4 25.5 4.4 26.6 83.8 34.1 217.3
Rural 3 months to below 5 years in all
districts
SP 5.7 2.7 0.7 6 0.7 6.3 22.7 4.6 49.4
AQ 17 8 2 17.9 2.2 19 68 13.9 148.2
3 months to below 10 years in SMC
districts with PAPfPR2-10 5% to 10%
and 3 months to below 5 years in
districts >10% PAPfPR2-10
SP 5.7 3.1 1.1 6.1 1.5 7.5 22.7 7.3 54.8
AQ 17 9.2 3.4 18.2 4.4 22.4 68 21.8 164.4
doi:10.1371/journal.pone.0136919.t003
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transmission has declined, such as in various parts of the Sahel and sub-Sahel [5], in part due
to malaria control interventions including SMC, the age pattern of P. falciparum infections and
disease are likely to decline with more older children becoming ill [7, 8, 25]. Consequently, the
impact of SMC on the burden of malaria may be greater if children above the age of five years
are targeted. There is no clear evidence on the upper age limit of children for inclusion or the
exact levels of transmission that determine when such a switch should be made. However, the
literature suggests a shift in the age pattern of infection and disease occurs under hypoendemic
transmission conditions [7, 8], corresponding to PAPfPR2-10 of10%. In this study, we esti-
mate that if children up to<10 years of age were included in heath districts where PAPfPR2-10
of was 5% to10%, an additional 19 million children overall, including 15 million children in
rural areas, would require SMC in the period 2015–2020. Approximately 10 million of these
children would be from Senegal, the only Nouakchott Initiative country that has already
decided to expand the age class of SMC targeted children to include those under 10 years of
age. However, as local data on the age distribution of malaria become available, and evidence
on the benefits of increasing the upper age limits accumulates, countries may consider increas-
ing the age of children to be targeted for SMC to beyond 10 years.
Our analysis indicates that Nigeria (northern), Mali and Burkina Faso account for over 60%
of all children living in areas suitable for SMC. From a Nouakchott Initiative regional perspec-
tive a bigger impact may be achieved by prioritising these countries. However, the potential
impact of SMC is not determined by the size of the population at risk alone but also the
strength of the health system tasked to deliver the intervention, the availability of domestic
resources in addition to external funding to sustain coverage and other factors such as conflict,
general good governance and conflict. In addition, where regional initiatives exist, prioritising
one country over another, without the requisite political goodwill, may lead to tension. Deci-
sions on prioritising high population at risk and potentially high return countries must there-
fore be done on the basis of regional agreements and the existing operational environment to
ensure maximum impact. Overall, the primary objective should be that resources are made
available to all those countries that are likely to benefit from SMC.
The reliability of the various inputs into the spatial decision support framework drive the
overall accuracy of the definition of the SMC target health districts and the quantification of
the size of the target population of children and the required tablets. Wide variations exist in
the number of transmission months within the SMC suitable areas of Sahel and sub-Sahel [17],
key factor to quantifying the required tablets and other operational inputs. In our analysis we
incorporate this information into the decision process and show that up to 289 million com-
bined tablets of AS and AQ would be required in 2015 alone to achieve universal coverage
across the region. Despite, their obvious epidemiological and operational importance [1, 26]
definitions of malaria seasonality, start and length of seasons still remain poorly described.
Various theoretical relationships between transmission intensity and climate indicators, specif-
ically temperature, rainfall and humidity, have been used to define malaria seasonality, its
beginning and its length [6, 17, 27]. In our current analysis, several districts in the southern
margins of the Sahel are classified to have five or six median number of transmission months.
This could be as a result of the uncertainties in the maps of transmission months we used [17]
or that of the seasonality surface (Fig 2A), whose bounds may be covering areas of high trans-
mission where seasonality is less acute with longer transmission period. For these districts, we
suggest that countries use the WHO recommendation of up to 4 months of SMC intervention
[3]. Further work using larger empirical malaria and higher resolution climate data are, how-
ever, required to improve the precision of these seasonality models. Studies in the agriculture
sector on forecasting of rainfall seasons to inform the crop-growing periods in rainfed crop
production systems in the Sahel [28, 29, 30] could provide useful lessons for SMC.
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The model-based geostatistical methods use to predict PfPR2-10 indicate reasonable accu-
racy based on the prediction to a carefully selected holdout dataset [5]. However, our estimates
of contemporary risk are to 2010 and countries need to update these maps as new survey data
become available. This will help the continuous process of deciding when and where to update
the upper age limit of children to be targeted for SMC. The population distribution maps,
which are used to compute both the PAPfPR2-10 and the size of SMC population, are also based
on modelled redistribution of census data, the accuracy of which is largely determined by the
spatial resolution and the currency of this data [12]. All the countries in this study have had a
census since 2009, except for Burkina Faso and Nigeria where the last censuses were done in
2006 [Table B in S1 File]. Despite the recent censuses, data used to develop the high-resolution
population maps were only available at the second administrative unit, the equivalent of a dis-
trict, for Chad, The Gambia and Mauritania.
Finally, we have considered P. falciparum, by far the most pathogenic of the four malaria
parasites found in Africa. However, the Sahel sub-region does support P. vivax transmission
and significant numbers of clinical cases of P. vivax have been documented in Mauritania, and
increasingly in and around Nouakchott [31, 32]; Mali [33, 34], Burkina Faso [35] and Niger
[36]. Further work is required to define the true spatial extent of P. vivax in the Sahel and inves-
tigate the clinical significance of this parasite and its responsiveness to SMC using SP+AQ.
Conclusions
Our spatial decision support framework allows for a common platform for decision making for
SMC for the countries of the Nouakchott Initiative. From the estimated numbers of children to
be targeted with SMC for the period 2015–2020 and tablets required for 2015 alone, the region
clearly needs to invest substantial resources to reach universal coverage of SMC in areas that
are likely to benefit the most. Where the financial and opportunity costs of various delivery
mechanisms are known [37], our empirical estimates of SMC target population could provide
the denominator to support comprehensive costing of the SMC scale up across the Sahel and is
easily compatible with existing implementation toolkit from the WHO [16]. Several challenges
remain, however, including availability of sufficient prevalence data in Niger and Mauritania,
improving the measures of seasonality, the start and length of the transmission season, the
place of urban population in malaria chemoprevention and the understanding the true preva-
lence of P. vivax and the role of SMC to reduce its burden in the Sahel. In addition, there are
likely to be other sub Saharan African countries outside of the Sahel that meet both the disease
burden and seasonality criteria for SMC suitability [6] but where resistance to both SP and AQ
are high [3]. Experimental evaluations of different therapeutic agents are required to expand
the benefits of SMC to these countries.
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S1 File. Supplementary Information for Sub-national targeting of seasonal malaria chemo-
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